West Chester Capital Advisors, Inc Eli Lilly & CO Transaction History

West Chester Capital Advisors, Inc

$52.2 Million
Q3 2023

A detailed history of West Chester Capital Advisors, Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, West Chester Capital Advisors, Inc holds 2,925 shares of LLY stock, worth $2.31 Million. This represents 3.01% of its overall portfolio holdings.

Number of Shares

2,925

Previous 3,004 2.63%

Holding current value

$2.31 Million

Previous $1.41 Million 11.58%

% of portfolio

3.01%

Previous 2.76%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$434.7 - $599.3 $34,341 - $47,344	-79 Reduced 2.63%	2,925 $1.57 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $659,391 - $881,682	-1,880 Reduced 38.49%	3,004 $1.41 Million
Q1 2023 May 04, 2023	SELL	$310.63 - $364.82 $621 - $729	-2 Reduced 0.04%	4,884 $1.68 Million
Q4 2022 Feb 06, 2023	SELL	$321.55 - $374.67 $7,395 - $8,617	-23 Reduced 0.47%	4,886 $1.79 Million
Q3 2022 Oct 31, 2022	SELL	$296.48 - $337.87 $8,004 - $9,122	-27 Reduced 0.55%	4,909 $1.59 Million
Q2 2022 Jul 28, 2022	SELL	$278.73 - $327.27 $18,953 - $22,254	-68 Reduced 1.36%	4,936 $1.6 Million
Q1 2022 May 03, 2022	SELL	$234.69 - $291.66 $24,642 - $30,624	-105 Reduced 2.06%	5,004 $1.43 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $20,011 - $24,834	89 Added 1.77%	5,109 $1.41 Million
Q3 2021 Nov 05, 2021	SELL	$221.6 - $272.71 $45,206 - $55,632	-204 Reduced 3.91%	5,020 $1.16 Million
Q2 2021 Jul 15, 2021	SELL	$180.55 - $233.54 $74,567 - $96,452	-413 Reduced 7.33%	5,224 $1.2 Million
Q1 2021 May 04, 2021	SELL	$164.32 - $212.72 $54,718 - $70,835	-333 Reduced 5.58%	5,637 $1.05 Million
Q4 2020 Feb 03, 2021	SELL	$130.46 - $172.63 $103,454 - $136,895	-793 Reduced 11.73%	5,970 $1.01 Million
Q3 2019 Nov 08, 2019	SELL	$106.79 - $116.16 $1,495 - $1,626	-14 Reduced 0.21%	6,763 $756,000
Q2 2019 Jul 30, 2019	SELL	$110.79 - $129.32 $2,769 - $3,233	-25 Reduced 0.37%	6,777 $751,000
Q1 2019 Apr 24, 2019	SELL	$111.31 - $131.02 $27,048 - $31,837	-243 Reduced 3.45%	6,802 $883,000
Q4 2018 Feb 07, 2019	SELL	$105.9 - $118.64 $86,838 - $97,284	-820 Reduced 10.43%	7,045 $815,000
Q3 2018 Oct 29, 2018	BUY	$85.86 - $107.31 $30,480 - $38,095	355 Added 4.73%	7,865 $844,000
Q2 2018 Jul 25, 2018	SELL	$75.7 - $86.88 $12,944 - $14,856	-171 Reduced 2.23%	7,510 $641,000
Q1 2018 May 04, 2018	SELL	$74.21 - $87.6 $16,474 - $19,447	-222 Reduced 2.81%	7,681 $594,000
Q4 2017 Feb 12, 2018	BUY	$81.94 - $87.89 $647,571 - $694,594	7,903	7,903 $669,000

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of West Chester Capital Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on West Chester Capital Advisors, Inc with notifications on news.

Account

West Chester Capital Advisors, Inc Eli Lilly & CO Transaction History